Day

August 25, 2026
Antimicrobial resistance has made the treatment of some Gram-negative bacterial infections increasingly challenging. Bacteria can develop multiple resistance mechanisms, including the production of beta-lactamases and metallo-beta-lactamases (MBLs). Meblanios is an injectable combination of Aztreonam and Avibactam that is relevant to this area of antimicrobial therapy. The combination brings together an antibacterial agent and a beta-lactamase...
Read More